# Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug

> **NCT00644839** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 28 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** CP-945,598
- **DRUG:** CP-945,598

## Key facts

- **NCT ID:** NCT00644839
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2009-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00644839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00644839, "Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00644839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*